The Effects of Focal Vibration on Spasticity in Multiple Sclerosis Patients
- Conditions
- Multiple Sclerosis
- Interventions
- Other: PlaceboDevice: Equistasi
- Registration Number
- NCT02848898
- Lead Sponsor
- Federico II University
- Brief Summary
This trial consists of application of little devices (named Equistasi®) generating focal vibrations to treat spasticity in neurological patients, affected by multiple sclerosis. The expected effects are on gait and postural instability.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 60
- Multiple Sclerosis affected
- Spasticity
- EDSS (Expanded Disability Status Scale) 0 - 5,5
- Patients able to sign informed consent
- Age less than 18 years old and more than 65 years old
- Pacemaker
- Pregnancy
- Comorbidities as: cancer, hypertension not controlled by drugs
- concurrent therapies with antidepressant or corticosteroids
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description Placebo Group Placebo arm treated with application of inactivated devices Equistasi Group Equistasi arm treated with application of devices
- Primary Outcome Measures
Name Time Method Double support time one year double support time measured in seconds
Stance phase one year stance phase measured in seconds
Gait Velocity one year evaluation of gait velocity in m/s
First step length one year first step length in cm
Swing phase one year swing phase measured in seconds
- Secondary Outcome Measures
Name Time Method Berg Balance Scale one year Evaluation of balance with a self administered scale, measured in Unit
H/M ratio one year evaluation of neurophysiological modifications in treated patients vs placebo group, as ratio between H max and M max in tibial posterior nerve, in Unit
Modified Fatigue Scale one year evaluation of fatigue with a self administered scale, measured in Unit
Trial Locations
- Locations (1)
Prof. Giuseppe Orefice
🇮🇹Naples, Campania, Italy